NorthWest Biotherapeutics Inc (NWBO)

[pqr]

no2 and hoff: agree. No matter the claims or evidence, prediction of litigation outcomes is always going to be uncertain. So a defendant needs to assess likelihood of an ABMD verse outcome, but also magnitude of exposure including foreseeable repercussions (SEC inquiry and reputational harm) as well as distraction from revenue-producing activities.